Tesamorelin: Peptide Identity and Research Documentation
Tesamorelin is a synthetic peptide based on the 44-amino-acid sequence of human growth hormone-releasing factor, with a modification at its N-terminus. For laboratory researchers, the useful starting point is a precise identity: which molecule is described, which chemical form is supplied and which analytical records belong to the lot?
What is tesamorelin?
The FDA’s chemistry review describes tesamorelin acetate as an analogue of human growth hormone-releasing factor, also called GRF. Its structure includes a trans-3-hexenoyl group attached at the N-terminal tyrosine. That modification is part of the molecular identity; tesamorelin should not simply be treated as an interchangeable name for unmodified GRF(1–44). Source: FDA chemistry review, NDA 022505.
Tesamorelin and tesamorelin acetate: what should be specified?
A peptide name and a salt-form designation answer related but different questions. The cited chemistry review distinguishes tesamorelin from its acetate form and describes acetate counterions separately from the peptide structure. When reviewing a material, record the declared chemical form rather than assuming it from a shortened product name.
Ask whether a reported quantity refers to peptide content, a salt-form quantity or total supplied material. If the basis is unclear, request clarification before comparing numbers from different documents. A matching name does not resolve a mismatch in reporting basis.
How should researchers review material identity?
Begin with the specification, then compare it with the lot-specific report. A useful review records the full peptide identity, stated modifications, chemical form, lot identifier and the methods used to support the assignment.
Keep identity and purity as separate questions. An identity result asks whether the measured material is consistent with the assigned molecule. A purity result describes a measurement under a particular analytical method. Neither question should disappear behind a single headline percentage.
What belongs in a tesamorelin documentation review?
- Material identity: the named peptide, modifications and declared chemical form.
- Traceability: a lot number that matches the label and the analytical report.
- Method information: the technique used for each reported result and enough context to interpret it.
- Reporting basis: clear distinctions between purity, content and total material quantity.
- Report provenance: the issuing laboratory, report identifier and relevant dates.
- Study relevance: documentation appropriate to the planned laboratory question.
This is a review framework, not a statement that any particular supplier performs every listed test. Our guide to reading a certificate of analysis explains how to connect individual results to a supplied lot.
Why should literature and supplier documentation be read separately?
A publication or regulatory document describes the material and work within its own scope. It does not authenticate a separately supplied research lot. Likewise, a research-material listing should not be represented as equivalent to an approved finished medicine.
Use primary references to establish terminology and the context of a study. Use relevant lot-specific documentation to evaluate the supplied material. For another common distinction in analytical reports, see HPLC purity versus assay.
Frequently asked questions
Is tesamorelin the same as unmodified GRF(1–44)?
No. The N-terminal modification is part of tesamorelin’s defined identity.
Does an acetate designation replace the need for an identity report?
No. It specifies chemical form; it does not establish the identity of a particular supplied lot.
Does a high purity percentage answer every quality question?
No. Review identity, reporting basis and traceability alongside the purity result.
Does this article provide human-use guidance?
No. It addresses molecular identity and laboratory documentation, without dosing, administration or treatment recommendations.
Reference
U.S. Food and Drug Administration. Chemistry review for NDA 022505 (2010). Cited for molecular identity and chemical-form terminology, not as evidence about any Aurevia Research material.
CONTINUE WITH AUREVIA
Your next research step.
Conducting laboratory research? Create a research account, or ask us about material identity and lot-specific analytical documentation.
For laboratories and independent individuals conducting genuine laboratory research. First orders are verified before shipping. Not for human or veterinary use.